Cyclacel pharmaceuticals to present at biotech showcase 2024

Berkeley heights, n.j., jan. 02, 2024 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced today that spiro rombotis, president & chief executive officer, will present an overview of its business and provide updates on its clinical programs at biotech showcase, taking place january 8-10, 2024 in san francisco, california.
CYCC Ratings Summary
CYCC Quant Ranking